Interestingly, primary human lung apCAFs derived from ATII rather than cancer or mesothelial cells [44, 55] exhibit certain anti-tumor effects by directly activating T cell receptors (TCRs) in tumor-infiltrating CD4 + T cells and shielding them from apoptosis. This evidence concerns the gene CD4 and neoplasm.